Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Acquisitions & Divestments (2021 - 2025)

Historic Change in Acquisitions & Divestments for Krystal Biotech (KRYS) over the last 5 years, with Q3 2025 value amounting to $95.8 million.

  • Krystal Biotech's Change in Acquisitions & Divestments rose 2087.19% to $95.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $350.4 million, marking a year-over-year increase of 1206.93%. This contributed to the annual value of $298.5 million for FY2024, which is 4067.34% down from last year.
  • Latest data reveals that Krystal Biotech reported Change in Acquisitions & Divestments of $95.8 million as of Q3 2025, which was up 2087.19% from $105.3 million recorded in Q2 2025.
  • Krystal Biotech's 5-year Change in Acquisitions & Divestments high stood at $161.2 million for Q2 2023, and its period low was $1.2 million during Q2 2021.
  • In the last 5 years, Krystal Biotech's Change in Acquisitions & Divestments had a median value of $74.6 million in 2023 and averaged $72.7 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 499261.96% in 2022, then tumbled by 5883.06% in 2024.
  • Over the past 5 years, Krystal Biotech's Change in Acquisitions & Divestments (Quarter) stood at $21.0 million in 2021, then soared by 395.73% to $104.1 million in 2022, then decreased by 28.33% to $74.6 million in 2023, then decreased by 18.9% to $60.5 million in 2024, then surged by 58.35% to $95.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $95.8 million in Q3 2025, compared to $105.3 million in Q2 2025 and $88.8 million in Q1 2025.